Company Quick10K Filing
Enerteck
10-Q 2021-03-31 Filed 2021-05-24
10-K 2020-12-31 Filed 2021-03-31
10-Q 2020-09-30 Filed 2020-11-13
10-Q 2020-06-30 Filed 2020-08-14
10-Q 2020-03-31 Filed 2020-06-29
10-K 2019-12-31 Filed 2020-05-14
10-Q 2019-09-30 Filed 2019-11-14
10-Q 2019-06-30 Filed 2019-08-14
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-16
10-Q 2018-03-31 Filed 2018-05-25
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-16
10-Q 2016-03-31 Filed 2016-05-19
10-K 2015-12-31 Filed 2016-05-09
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-18
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-06-30 Filed 2014-08-13
10-K 2013-12-31 Filed 2014-04-15
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-08-14
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-16
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-12
10-Q 2011-03-31 Filed 2011-05-16
10-K 2010-12-31 Filed 2011-04-15
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-13
10-Q 2010-03-31 Filed 2010-05-13
10-K 2009-12-31 Filed 2010-03-31
8-K 2020-05-15
8-K 2020-03-30
8-K 2018-01-30

Enerteck Financials

ETCK Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash66693744611522421705691941828811718106221065851941312112521512
Accounts Receivable2073102001872181439111810734764575603068505640142461154166197731131010
Inventory20923728228227529930729834734125524423823116916718017616015514713512912913912712512312210562605955
PP&E73665852484455483931221814117531222223333322270270270270
Assets7388541,075762735709639695758642523536561562375534446429431434438434337375376336352414385340318369318291
Accounts Payable224263437178187157239106185156146158173165161166181197181175171203175189195140131120126133124169213210
Long-Term Debt1,8401,8401,8401,840
Liabilities2,6222,9593,2553,1853,5353,8634,2524,4944,6584,7664,9895,2615,6085,8195,9846,1645,4745,7626,0366,3446,6126,8607,0507,2887,5527,6287,8837,0307,2757,3707,5837,9558,2458,494
Stockholders' Equity-1,884-2,105-2,181-2,423-2,800-3,154-3,614-3,799-3,900-4,124-4,466-4,725-5,047-5,257-5,609-5,630-5,028-5,334-5,605-5,910-6,175-6,426-6,713-6,913-7,176-7,293-7,531-6,616-6,891-7,030-7,265-7,586-7,926-8,203
Income Statement ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue23313507330228314343754234795681102591013317912
Cost of Revenue35180316514331313-2556112141112233325
Gross Profit2026170422517691103047626729275163175729446726879147-17981001377
R&D
SG&A7199002942653393734043403644304362743082923253633202772852862841,330436241291215127204215248279
Tax0000000000000000000000000000
Net Income-757-946-201-342227-433-459-356-304-482-486259-98-313-397-359-311-305-280-305-288-1,323-451-206850-221-242-238-275-185-321-341-276
Cash Flow ($'000)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-96235-428-159-102-74-401-157-99-128-90-128-112-94-244-99-109-75-174-108-112-59-91-117-1069-244-150-48-178-137-118
Cash Investing-200-1-2-3-200000000-00-330-100-20-10000
Cash Financing1007010012514550400206858010015015320318351101001701251005591120103626614038218100115